Rock Springs Capital Management LP

Position in VERA — Vera Therapeutics, Inc.

CIK 1595725 Baltimore, MD

Position in VERA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$18,347,629

-$1,911,595 QoQ

Shares Held

427,584

-15.1% QoQ

Ownership

0.593%

of shares outstanding

% of Portfolio

0.90%

of 13F equity value

Holder Rank

#38

of 217 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rock Springs Capital Management LP holds $1,502,002,537 across 70 Biotechnology names. VERA ranks #26 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	1,105,210	$206,983,728
2	TVTX	Travere Therapeutics, Inc.	2,179,069	$123,792,909
3	MDGL	Madrigal Pharmaceuticals, Inc.	174,999	$93,965,713
4	MIRM	Mirum Pharmaceuticals, Inc.	798,145	$93,438,835
5	RYTM	Rhythm Pharmaceuticals, Inc.	692,598	$76,899,155
6	KYMR	Kymera Therapeutics, Inc.	453,156	$51,963,398
7	ARGX	Argenx SE	52,750	$48,939,867
8	ASND	Ascendis Pharma A/S	168,750	$45,009,000

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,347,629	427,584	-15.1%	Shares	Sole	2026-08-14
2026-03-31	$20,259,224	503,585	-11.4%	Shares	Sole	2026-05-15
2025-12-31	$28,792,840	568,579	-7.9%	Shares	Sole	2026-02-17
2025-09-30	$17,941,527	617,396	0.0%	Shares	Sole	2025-11-14
2025-06-30	$14,545,849	617,396	+18.5%	Shares	Sole	2025-08-14
2025-03-31	$12,509,519	520,796	+6.8%	Shares	Sole	2025-05-15
2024-12-31	$20,631,726	487,863	+27.2%	Shares	Sole	2025-02-14
2024-09-30	$16,950,346	383,492	+0.6%	Shares	Sole	2024-11-14
2024-06-30	$13,791,526	381,192	+11.7%	Shares	Sole	2024-08-14
2024-03-31	$14,711,164	341,168	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.